Come on fellas, same Team. Tom if it goes back to fill gap congrats. I think it doesn’t matter either way as future valuations with commercial agreements should be significantly higherGL
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025